Histoplasma panniculitis in dermatomyositis

Journal of Clinical Rheumatology

Volumn 3, Issue 6, 1997, Pages 353-357

  Frias, Juan P ^c   Huston III, Joseph W ^a,b   McNabb II, Paul C ^a,b  

^a Baptist Hospital Nashville   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NONE

Author keywords

Dermatomyositis; Histoplasmosis; Panniculitis

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DERMATOMYOSITIS; FEMALE; HEPATOSPLENOMEGALY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFILTRATE; LYMPHADENOPATHY; MOUTH ULCER; PANNICULITIS; PRIORITY JOURNAL;

EID: 0031406336     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199712000-00011     Document Type: Article

References (29)

1. Winkelmann RK. Panniculitis in connective tissue disease. Arch Dermatol 1983;119:336-44.
2. Weber FP, Gray AMH. Chronic relapsing polydermatomyositis with predominant involvement of the subcutaneous fat (panniculitis). Br J Dermatol 1924;36:544-60.
3. Kuyria N, Kinoshita N, Yokoyama N, Fukada T, Eguchi K, Tsujihata M, et al. Dermatomyositis with rhabdomyosarcoma and panniculitis: report of an autopsy case. Nippon Naika Gakkai Zasshi 1985;74:813-8.
4. Commens C, O'Neill P, Walker G. Dermatomyositis associated with multifocal lipoatrophy. J Am Acad Dermatol 1990;22:966-9.
5. Winkelman WJ, Billick RC, Srolovitz H. Dermatomyositis presenting as panniculitis. J Am Acad Dermatol 1990;23:127-8.
6. Fusade T, Belanyi P, Joly P, Thornine E, Mihout M, Lauret P. Subcutaneous changes in dermatomyositis. Br J Dermatol 1992;128:451-3.
7. Sabroe RA, Wallington TB, Kennedy CT. Dermatomyositis treated with high-dose intavenous immunoglobulins and associated with panniculitis. Clin Exp Dermatol 1995;20:164-7.
8. Neidenbach PJ, Sahn EE, Helton J. Panniculitis in juvenile dermatomyositis. J Am Acad Dermatol 1995;33:305-7.
9. Raimer SS, Solomon AR, Daniels JC. Polymyositis presenting with panniculitis. J Am Acad Dermatol 1985;13:366-9.
10. Langenberg A, Egbert B. Neutrophilic tuberculosis panniculitis in a patient with polymyositis. J Cutan Pathol 1993;20:177-9.
11. Janis JF, Winkelmann RK. Histopathology of the skin in dermatomyositis: a histopathologic study of 55 cases. Arch Dermatol 1968;97: 640-50.
12. Rifkind D, Marchiore TL, Schneck SA, Hill R. Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Am J Med 1967;43:28-37.
13. Park RK, Goltz RW, Carey TB. Unusual cutaneous infections associated with immunosuppressive therapy. Arch Dermatol 1967;95: 345-9.
14. Daman LA, Hashimoto K, Kaplan R, Trent W. Disseminated histoplasmosis in an immunosuppressed patient. South Med J 1977;70:355-6.
15. Abildgaard WH, Hargrove RH, Kalivas J. Histoplasma panniculitis. Arch Dermatol 1985; 121:914-6.
16. Silverman AK, Gilbert SC, Watkins D, Cooper B, Menter A. Panniculitis in an immunocompromised patient. J Am Acad Dermatol 1991; 24:912-4.
17. Patterson JW, Brown PC, Broecker AH. Infection-induced panniculitis. J Cutan Pathol 1989; 16:183-93.
18. Goodwin RA, Loyd JE, DesPrez RM. Histoplasmosis in normal hosts. Medicine 1981;60: 231-66.
19. Wheat LJ, Slama TG, Eitzen HE, Kohler B, French M, Biesecker J. A large outbreak of histoplasmosis: clinical features. Ann Intern Med 1981;94:331-7.
20. Wheat LJ, Slama TG, Norton JA, Kohler RB, Eitzen HE, French M, et al. Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med 1982;96:159-63.
21. Medeiros AA, Marly SD, Tosh FE, Chin TD. Erythema nodosum and erythema multiforme as clinical manifestations of histoplasmosis in a community outbreak. N Eng J Med 1966;274: 415-20.
22. Ozols II, Wheat JL. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis. Arch Dermatol 1981;117:709-12.
23. Goodwin RA, Shapiro JL, Thurman GH, Thurman SS, DesPrez R. Disseminated histoplasmosis: Clinical and pathologic correlations. Medicine 1980;59:1-33.
24. Voloshin DK, Lacomis D, McMahon D. Disseminated histoplasmosis presenting as myositis and fasciitis in a patient with dermatomyositis. Muscle Nerve 1995;18:531-35.
25. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Eng J Med 1986;314:329-34.
26. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: A quantitative study. Ann neurol 1990;27: 343-56.
27. Kissel JT, Halterman RK, Rammohan KW, Mendell JR. The relationship of complement-mediated microvasculopthy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991;48:26-30.
28. Mascaro JM, Hausmann G, Herrero C, Grau J, Cid M, Palou J, et al. Membrane attack complex depositis in cutaneous lesions of dermatomyositis. Arch Dermatol 1993;131:1386-92.
29. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996;27:15-19.